Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study

Por Niho, S, Kubota, K, Goto, K, Ohmatsu, H, Matsumoto, T, Kakinuma, R, Nishiwaki, Yutaka
Publicado em 2002

Phase II study of high-dose dexamethasone-based association in acute and delayed high-dose cisplatin-induced emesis--JCOG study 9413.

Por Sekine, I., Nishiwaki, Y., Kakinuma, R., Kubota, K., Hojo, F., Matsumoto, T., Ohmatsu, H., Yokozaki, M., Goto, K., Miyamoto, T., Takafuji, J., Kodama, T.
Publicado em 1997

Phase I study of sequentially administered topoisomerase I inhibitor (irinotecan) and topoisomerase II inhibitor (etoposide) for metastatic non-small-cell lung cancer.

Por Ando, M., Eguchi, K., Shinkai, T., Tamura, T., Ohe, Y., Yamamoto, N., Kurata, T., Kasai, T., Ohmatsu, H., Kubota, K., Sekine, I., Hojo, N., Matsumoto, T., Kodama, T., Kakinuma, R., Nishiwaki, Y., Saijo, N.
Publicado em 1997

Phase I/II trial of weekly cisplatin, etoposide, and irinotecan chemotherapy for metastatic lung cancer: JCOG 9507

Por Sekine, I, Nishiwaki, Y, Kakinuma, R, Kubota, K, Hojo, F, Matsumoto, T, Ohmatsu, H, Goto, K, Kodama, T, Eguchi, K, Shinkai, T, Tamura, T, Ohe, Y, Kunitoh, H, Yoshimura, K, Saijo, N
Publicado em 2003

Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer

Por Goto, K, Sekine, I, Nishiwaki, Y, Kakinuma, R, Kubota, K, Matsumoto, T, Ohmatsu, H, Niho, S, Kodama, T, Shinkai, T, Tamura, T, Ohe, Y, Kunitoh, H, Yamamoto, N, Nokihara, H, Yoshida, K, Sugiura, T, Matsui, K, Saijo, N
Publicado em 2004

Comparison of sensitivity of lung nodule detection between radiologists and technologists on low-dose CT lung cancer screening images

Por Kakinuma, R, Ashizawa, K, Kobayashi, T, Fukushima, A, Hayashi, H, Kondo, T, Machida, M, Matsusako, M, Minami, K, Oikado, K, Okuda, M, Takamatsu, S, Sugawara, M, Gomi, S, Muramatsu, Y, Hanai, K, Muramatsu, Y, Kaneko, M, Tsuchiya, R, Moriyama, N
Publicado em 2012